Evidence map›Paper›PMID 42255238›Full record

ArticleFrontiers in oncology2026

Combined chemotherapy with sequential allogeneic hematopoietic stem cell transplantation successfully treats primary plasma cell leukemia: a case report.

Xiushuai Dong, Jinghua Wang, Yaoyao Tian, Lianjie Wang, Wei Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiushuai DongDepartment of Hematology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Jinghua WangDepartment of Hematology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Yaoyao TianDepartment of Hematology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Lianjie WangDepartment of Hematology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Wei WangDepartment of Hematology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary plasma cell leukemia (pPCL) is an extremely aggressive and rare subtype of plasma cell neoplasm with extremely poor prognosis, and optimal treatment strategies remain controversial due to its low incidence. This case is unique in that it reports long-term disease-free survival after combination chemotherapy followed by allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT), which provides valuable real-world evidence supporting the potential curative role of this sequential therapeutic approach for pPCL, a disease where long-term survival is rarely achieved with conventional treatments.

Indexed as

allogeneic hematopoietic stem cell transplantationcase reportchemotherapylong-term survivalprimary plasma cell leukemia

Identifiers

PMID42255238
PMCPMC13236491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.